To advance our understanding of AD pathology and facilitate drug screening efforts, we used multiple cell lines and NSC models derived from iPSCs of patients with AD to study LRP1-mediated Aβ clearance (Figs. 3 and 7 and fig. This evidence concerns the gene LRP1 and Alzheimer disease.